FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 140 filers reported holding FATE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -50.0% | 360 | 0.0% | 0.00% | – |
| Q2 2023 | $2 | 0.0% | 360 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | -50.0% | 360 | 0.0% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 360 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | -11.1% | 360 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -18.2% | 360 | +29.0% | 0.00% | – |
| Q1 2022 | $11,000 | -31.2% | 279 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -15.8% | 279 | -14.4% | 0.00% | – |
| Q3 2021 | $19,000 | +18.8% | 326 | +75.3% | 0.00% | – |
| Q2 2021 | $16,000 | +6.7% | 186 | 0.0% | 0.00% | – |
| Q1 2021 | $15,000 | 0.0% | 186 | +13.4% | 0.00% | – |
| Q4 2020 | $15,000 | -25.0% | 164 | -66.5% | 0.00% | – |
| Q3 2020 | $20,000 | +122.2% | 490 | +19.5% | 0.00% | – |
| Q2 2020 | $9,000 | 0.0% | 410 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | +12.5% | 410 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | +33.3% | 410 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | -25.0% | 410 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | +14.3% | 410 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | 0.0% | 410 | -25.5% | 0.00% | – |
| Q4 2018 | $7,000 | – | 550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 716,392 | $11,126,000 | 12.18% |
| Polaris Venture Management Co. V, L.L.C. | 1,139,783 | $17,701,000 | 10.06% |
| Grosvenor Holdings, L.L.C. | 2,285,714 | $35,497,000 | 6.41% |
| Redmile Group, LLC | 11,216,809 | $174,197,000 | 5.83% |
| Casdin Capital, LLC | 2,550,000 | $39,601,500,000 | 4.10% |
| DAFNA Capital Management LLC | 470,000 | $7,299,000 | 2.74% |
| Ghost Tree Capital, LLC | 350,000 | $5,436,000 | 1.38% |
| Artal Group S.A. | 2,000,000 | $31,060,000 | 1.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,952,897 | $30,328,000 | 1.24% |
| Copernicus Capital Management, LLC | 75,000 | $1,165,000 | 1.08% |